近期，武漢大學(xué)黃衛(wèi)華團(tuán)隊(duì)、廈門大學(xué)Christian Amatore團(tuán)隊(duì)合作在《Nature Nanotechnology》（IF=38.8）上發(fā)表題為“Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres”（納米電極監(jiān)測(cè)巨噬細(xì)胞受挫性吞噬納米纖維過程中ROS/RNS泄漏）的研究，報(bào)告了一種電化學(xué)納米傳感器，用于監(jiān)測(cè)和定量表征單個(gè)巨噬細(xì)胞對(duì)玻璃納米纖維的吞噬作用受阻期間活性物質(zhì)釋放的通量和動(dòng)態(tài)。

機(jī)體吸入環(huán)境暴露的高長(zhǎng)徑比惰性納米纖維（石棉、玻璃纖維、碳納米管等）后，肺泡巨噬細(xì)胞會(huì)迅速識(shí)別這些異物，并試圖將其吞噬。由于纖維狀材料的高長(zhǎng)徑比和難于分解的特性，巨噬細(xì)胞難以將其快速清除，從而形成受挫性吞噬作用（frustrated phagocytosis）。在此過程中，巨噬細(xì)胞內(nèi)的NADPH氧化酶（NOX）和誘導(dǎo)型一氧化氮合酶（iNOS）會(huì)持續(xù)產(chǎn)生活性氧和活性氮（ROS/RNS）消化纖維。由于吞噬腔未封閉，大量產(chǎn)生的ROS/RNS可能會(huì)從吞噬口泄漏到胞外，對(duì)周圍肺組織細(xì)胞造成損傷并引發(fā)疾病。在過去幾十年里，研究人員采用ROS/RNS染色以及活體實(shí)驗(yàn)對(duì)碳納米管和石棉等納米纖維材料的研究均支持這一假設(shè)。然而，因缺乏合適的傳感器，該過程中各類活性物質(zhì)的化學(xué)組成及其時(shí)空動(dòng)態(tài)變化特征仍然未知。

?

針對(duì)受挫性吞噬作用假說，研究團(tuán)隊(duì)將鉑黑納米線電化學(xué)傳感器（SiC@PtNWS）定位在巨噬細(xì)胞吞噬口處，從而實(shí)現(xiàn)對(duì)受挫性吞玻璃納米纖維的過程中4種主要ROS/RNS（ONOO-，H2O2，NO和NO2-）泄漏通量的實(shí)時(shí)定量監(jiān)測(cè)。結(jié)果表明，在吞噬各階段，ROS/RNS釋放存在明顯時(shí)間差異。相較于細(xì)胞頂部，吞噬口處存在大量ROS/RNS泄漏，且隨吞噬進(jìn)行持續(xù)增加直到吞噬口封閉泄漏。NOX和iNOS參與動(dòng)態(tài)調(diào)控ROS/RNS的物質(zhì)組成。相關(guān)數(shù)據(jù)定量展示了單個(gè)巨噬細(xì)胞受挫性吞噬作用玻璃納米纖維時(shí)ROS/RNS產(chǎn)生的時(shí)空特征，從而描繪出巨噬細(xì)胞應(yīng)對(duì)惰性高長(zhǎng)徑納米材料的動(dòng)態(tài)免疫調(diào)節(jié)過程。體外共培養(yǎng)和活體實(shí)驗(yàn)進(jìn)一步表明，持續(xù)且大量的ROS/RNS泄漏會(huì)導(dǎo)致外周細(xì)胞嚴(yán)重受損，最終轉(zhuǎn)化為慢性炎癥和肺損傷。

?

在該項(xiàng)研究中，使用了欣博盛生物（NeoBioscience Technology Co, Ltd）的QuantiCyto^??Mouse IL-1α?ELISA kit（小鼠白細(xì)胞介素-1α），用于培養(yǎng)上清液中該細(xì)胞因子含量的測(cè)定。

欣博盛生物非常榮幸能夠作為供應(yīng)商為該項(xiàng)研究提供高品質(zhì)ELISA試劑盒，為生物醫(yī)學(xué)領(lǐng)域的科研探索貢獻(xiàn)一份力量。

?

1.?Nanosensor detection of reactive oxygen and nitrogen species leakage in frustrated phagocytosis of nanofibres?(Nature Nanotechnology, IF=38.3)

發(fā)表時(shí)間：03 January 2024

作 ???者：Qi Y T, Zhang F L, Tian S Y, et al.

作者單位：武漢大學(xué)

使用產(chǎn)品：Mouse IL-1α ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38172432/

?

2.?Extracellular Matrix-Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity?(Advanced Materials, IF=29.4）

發(fā)表時(shí)間：12 January 2024

作 ???者：Wu Y, Li Y, Hu Z, et al.

作者單位：上海藥物研究所?

使用產(chǎn)品：Mouse TGF-β1, TNF-α, RANTES/CCL5 and IP-10/CXCL10 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38216153/

?

3.?Pro-Regenerative Glycopeptide Hydrogel Activates Type 2 Immune Response for Wound Healing via Macrophage-T Cell Crosstalk?(Advanced Functional Materials, IF=19)

發(fā)表時(shí)間：02 January 2024

作 ???者：Wang J, Liu X, Wang Y, et al.

作者單位：中國醫(yī)學(xué)科學(xué)院

使用產(chǎn)品：Mouse IgG1 ELISA kit

https://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.202307711

?

4.?Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy?(Bioactive Materials, IF=18.9)

發(fā)表時(shí)間：13 January 2024

作 ???者：Li?P, Xie Y, Wang J, et al.

作者單位：北京大學(xué)

使用產(chǎn)品：Mouse PD1 ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38292412/

?

5.?Targeted mRNA Nanoparticles Ameliorate Blood–Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization?(ACS nano, IF=17.1)

發(fā)表時(shí)間：16 January 2024

作 ???者：Gao M, Li Y, Ho W, et al.

作者單位：上海交通大學(xué)

使用產(chǎn)品：Mouse IL-10, TNF-α, and TGF-β ELISA kits

樣本類型：腦組織

https://pubmed.ncbi.nlm.nih.gov/38227975/

?

6.?TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5′UTR, and IL?15 against experimental glioblastoma?(Journal of Medical Virology, IF=12.7)

發(fā)表時(shí)間：January 2024

作 ???者：Wang J, Zhang J, Zhang Q, et al.

作者單位：首都醫(yī)科大學(xué)北京神經(jīng)外科研究所腦腫瘤研究中心

使用產(chǎn)品：Human IL-15 and MMP-3 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38149454/

?

7.?Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease?(Translational Neurodegeneration, IF=12.6)

發(fā)表時(shí)間：03 January 2024

作 ???者：Zhang M, Zhang Z, Li H, et al.

作者單位：中山大學(xué)

使用產(chǎn)品：Mouse VEGF ELISA kit

樣本類型：腦組織

https://pubmed.ncbi.nlm.nih.gov/38173017/

?

8.?DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma?(Journal of Experimental & Clinical Cancer Research, IF=11.3)

發(fā)表時(shí)間：02 January 2024

作 ???者：Wei S, Xing J, Chen J, et al.

作者單位：寧波大學(xué)附屬人民醫(yī)院

使用產(chǎn)品：Normal Goat Serum

https://pubmed.ncbi.nlm.nih.gov/38163876/

?

9.?Curdlan-Decorated Fullerenes Mitigate Immune-Mediated Hepatic Injury for Autoimmune Hepatitis Therapeutics via Reducing Macrophage Infiltration?(ACS Applied Materials & Interfaces, IF=9.5)

發(fā)表時(shí)間：24 January 2024

作 ???者：Fei C, Liu L, Qi H, et al.

作者單位：中國科學(xué)院化學(xué)研究所

使用產(chǎn)品：Mouse TNF-α and IL-6 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38267397/

?

10.?BACH2-mediated CD28 and CD40LG axes contribute to pathogenesis and progression of T-cell lymphoblastic leukemia?(Cell Death & Disease, IF=9)

發(fā)表時(shí)間：17 January 2024

作 ???者：Feng M, Zhang B, Li G, et al.

作者單位：中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院

使用產(chǎn)品：Human IL-6 and IL-8 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38233409/

?

11.?Targeted delivery of rosuvastatin enhances treatment of HHcy-induced atherosclerosis using macrophage membrane-coated nanoparticles?(Journal of Pharmaceutical Analysis, IF=8.8)

發(fā)表時(shí)間：13 January 2024

作 ???者：Liu D, Yang A, Li Y, et al.

作者單位：寧夏醫(yī)科大學(xué)

使用產(chǎn)品：Mouse IL-1β and IL-18 ELISA kits

https://www.sciencedirect.com/science/article/pii/S209517792400025X

?

12.?Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma?(Cell Communication and Signaling, IF=8.4)

發(fā)表時(shí)間：30 January 2024

作 ???者：Yang Y, Wang S, Wang X, et al.

作者單位：空軍軍醫(yī)大學(xué)

使用產(chǎn)品：Human IL-6, TNF-α, MIG/CXCL9, IP-10/CXCL10, I-TAC/CXCL11 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38291473/

?

13.?Egr-1 is a key regulator of the blood-brain barrier damage induced by meningitic Escherichia coli?(Cell Communication and Signaling, IF=8.4)

發(fā)表時(shí)間：17 January 2024

作 ???者：Yang R, Wang X, Liu H, et al.

作者單位：華中農(nóng)業(yè)大學(xué)

使用產(chǎn)品：Mouse VEGF-A and PDGF-BB ELISA kits

樣本類型：腦組織

https://pubmed.ncbi.nlm.nih.gov/38233877/

?

14.?Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling?(Materials Today Bio, IF=8.2)

發(fā)表時(shí)間：24 January 2024

作 ???者：Shi Q, Xia Y, Wu M, et al.

作者單位：溫州醫(yī)科大學(xué)附屬第一醫(yī)院

使用產(chǎn)品：Mouse HGF and VEGF ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38327975/

?

15.?Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota?(International Journal of Biological Macromolecules, IF=8.2)

發(fā)表時(shí)間：January 2024

作 ???者：Jiang B, Wei M, He Y, et al.

作者單位：南昌大學(xué)

使用產(chǎn)品：Mouse TNF-α, IFN-γ, IL-2 and IL-6 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/37918610/

?

16.?Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching?(Acta Pharmacologica Sinica, IF=8.2)

發(fā)表時(shí)間：15 January 2024

作 ???者：Shen S, Xu J, Cheng C, et al.

作者單位：中國科學(xué)技術(shù)大學(xué)

使用產(chǎn)品：Mouse TGF-β and CCL2 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38225394/

?

17.?Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer?(Translational Research, IF=7.8)

發(fā)表時(shí)間：18 January 2024

作 ???者：Huang F, Zhao N, Cai P, et al.

作者單位：中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院

使用產(chǎn)品：Mouse IL-6 and TNF-α ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38244769/

?

18.?Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis?(Biomedicine & Pharmacotherapy, IF=7.5)

發(fā)表時(shí)間：January 2024

作 ???者：Lv C, Hu C, Zhu C, et al.

作者單位：華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬同濟(jì)醫(yī)院

使用產(chǎn)品：Mouse IL-17, IL-23 and IL-18 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38042114/

?

19.?LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy?(Oncoimmunology, IF=7.2)

發(fā)表時(shí)間：January 2024

作 ???者：Shan J, Jing W, Ping Y, et al.

作者單位：鄭州大學(xué)第一附屬醫(yī)院

使用產(chǎn)品：Mouse IFN-γ and IL-2 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38125721/

?

20.?Lipocalin-2 promotes neutrophilic inflammation in nasal polyps and its value as biomarker?(Allergology International, IF=6.8)

發(fā)表時(shí)間：January 2024

作 ???者：Zhang C, Wang H, Hu L, et al.

作者單位：復(fù)旦大學(xué)

使用產(chǎn)品：Human IL-6 and IL-8 ELISA kits

樣本類型：鼻腔組織

https://pubmed.ncbi.nlm.nih.gov/37567832/

?

21.?EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation?(Plos Pathogens, IF=6.7)

發(fā)表時(shí)間：11 January 2024

作 ???者：Xu X, Zhu N, Zheng J, et al.

作者單位：中山大學(xué)孫逸仙醫(yī)院

使用產(chǎn)品：Human IL-8 ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38206974/

?

22.?Sporopollenin exine capsules modulate the function of microglial cells?(Biomaterials Science, IF=6.6)

發(fā)表時(shí)間：30 January 2024

作 ???者：Li M, Hu B, Wu Z, et al.

作者單位：廈門大學(xué)

使用產(chǎn)品：Mouse TNF-αand IL-1β ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38099812/

?

23.?LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α?(Oncogenesis, IF=6.2)

發(fā)表時(shí)間：25 January 2024

作 ???者：Jin Y, Peng Y, Xu J, et al.

作者單位：湖北醫(yī)科大學(xué)

使用產(chǎn)品：Mouse VEGF ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38272870/

?

24.?Chemical Composition and Antibacterial and Antiulcerative Colitis Activities of Essential Oil from Pruni Semen?(Journal of Agricultural and Food Chemistry, IF=6.1)

發(fā)表時(shí)間：03 January 2024

作 ???者：Wang Y L, Lang D Q, Wu C, et al.

作者單位：南方醫(yī)科大學(xué)

使用產(chǎn)品：Mouse TNF-α ELISA kit

樣本類型：腸組織

https://pubmed.ncbi.nlm.nih.gov/38169317/

?

25.?Effects of unfolding treatment assisted glycation on the IgE/IgG binding capacity and antioxidant activity of ovomucoid?(Food & Function, IF=6.1)

發(fā)表時(shí)間：02 January 2024

作 ???者：Xia X, Li J, Liang R, et al.

作者單位：遵義醫(yī)學(xué)院

使用產(chǎn)品：HRP-streptavidin

https://pubmed.ncbi.nlm.nih.gov/38047408/

?

26.?EZY-1 inhibits idiopathic pulmonary fibrosis by regulating M2-type macrophage differentiation?(Journal of Functional Foods, IF=5.6)

發(fā)表時(shí)間：January 2024

作 ???者：Wu J, Tu M, Wei T, et al.

作者單位：廣東醫(yī)科大學(xué)附屬醫(yī)院

使用產(chǎn)品：Mouse TGF-β ELISA kit

https://www.sciencedirect.com/science/article/pii/S1756464623005480

?

27.?Multiple bioactivities of choerospondin obtained from blossom of Citrus aurantium L. Var. Amara engl. And its anti-inflammation and anti-atherosclerosis action pathways?(Journal of Functional Foods, IF=5.6)

發(fā)表時(shí)間：January 2024

作 ???者：Hao K X, Shen C Y, Zhong R F, et al.

作者單位：華南理工大學(xué)

使用產(chǎn)品：Mouse IL-6, TNF-α and IL-1β ELISA kits

https://www.sciencedirect.com/science/article/pii/S1756464623005418

?

28.?Self-Assembling E2-Based Nanoparticles Improve Vaccine Thermostability and Protective Immunity against CSFV?(International Journal of Molecular Sciences, IF=5.6)

發(fā)表時(shí)間：02 January 2024

作 ???者：Song H, Abdullah S W, Pei C, et al.

作者單位：西北農(nóng)林科技大學(xué)

使用產(chǎn)品：Porcine?IFN-γ, IL-2?and IL-4?ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38203765/

?

29.?BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling?(International Immunopharmacology, IF=5.6)

發(fā)表時(shí)間：05 January 2024

作 ???者：Lin J, Deng W, Liao J, et al.

作者單位：廣西壯族人民醫(yī)院

使用產(chǎn)品：Human TNF-α, IFN-γ and IL-1β ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38041956/

?

30.?Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway?(International Immunopharmacology, IF=5.6)

發(fā)表時(shí)間：25 January 2024

作 ???者：Zhou N, Zhang Y, Jiao Y, et al.

作者單位：四川大學(xué)

使用產(chǎn)品：Mouse IL-1β and TNF-α ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38081102/

?

31.?Panax notoginseng saponin R1 improves glucocorticoid-inhibited airway epithelium repair via glucocorticoid receptor β?(International Immunopharmacology, IF=5.6)

發(fā)表時(shí)間：25 January 2024

作 ???者：Yang L, Xu M, Zhang L, et al.

作者單位：重慶醫(yī)科大學(xué)

使用產(chǎn)品：Mouse IL-33 and TSLP ELISA kits

樣本類型：肺泡灌洗液

https://pubmed.ncbi.nlm.nih.gov/38104367/

?

32.?PVB exerts anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB signaling pathways and ROS generation in neutrophils?(International Immunopharmacology, IF=5.6)

發(fā)表時(shí)間：05 January 2024

作 ???者：Ouyang J, Hong Y, Wan Y, et al.

作者單位：南方醫(yī)科大學(xué)

使用產(chǎn)品：Mouse IL-6 and CXCL-1 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38006749/

?

33.?Distribution profiles of phenolic compounds in a cultivar of wampee (Clausena lansium (Lour.) Skeels) fruits and in vitro anti-inflammatory activity?(Journal of Ethnopharmacology, IF=5.4)

發(fā)表時(shí)間：30 January 2024

作 ???者：Zeng F, Chen M, Yang S, et al.

作者單位：中國熱帶農(nóng)業(yè)科學(xué)院

使用產(chǎn)品：Mouse IL-6 and TNF-α ELISA kits

https://pubmed.ncbi.nlm.nih.gov/37704117/

?

34.?Qi-Zhi-Wei-Tong granules alleviates chronic non-atrophic gastritis in mice by altering the gut microbiota and bile acid metabolism?(Journal of Ethnopharmacology, IF=5.4)

發(fā)表時(shí)間：30 January 2024

作 ???者：Chen M, Li Y, Li L, et al.

作者單位：湖北中醫(yī)藥大學(xué)

使用產(chǎn)品：Mouse TNF-α and IL-1β ELISA kits

樣本類型：胃組織;腸道組織

https://pubmed.ncbi.nlm.nih.gov/37838294/

?

35.?Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis?(Journal of Ethnopharmacology, IF=5.4)

發(fā)表時(shí)間：10 January 2024

作 ???者：Liu Y, Tang A, Liu M, et al.

作者單位：貴州中醫(yī)藥大學(xué)

使用產(chǎn)品：Mouse IL-1β, IL-2, MCP-1, MIP-2, M-CSF, IL-6, TNF-α and IFN-γ ELISA kits

樣本類型：肺泡灌洗液

https://pubmed.ncbi.nlm.nih.gov/37532076/

?

36.?METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells?(Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, IF=5.1)

發(fā)表時(shí)間：January 2024

作 ???者：Huang J, Wang Y, Zhou Y.

作者單位：武漢大學(xué)口腔醫(yī)學(xué)院

使用產(chǎn)品：Human IL-6 ELISA kit

https://pubmed.ncbi.nlm.nih.gov/37821055/

?

37.?Fusobacterium nucleatum exacerbates the progression of pulpitis by regulating the STING-dependent pathway?(The FASEB Journal, IF=4.8)

發(fā)表時(shí)間：January 2024

作 ???者：Zhou L, Mao H Q, Li J Q, et al.

作者單位：武漢大學(xué)

使用產(chǎn)品：Mouse IFN-β ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38085169/

?

38.?Effects of medicine food homologous materials on food allergy-associated factors: intestinal oxidative stress, intestinal inflammation and Th2 immune response?(Journal of the science of food and agriculture, IF=4.1)

發(fā)表時(shí)間：24 January 2024

作 ???者：Xu X, Wang Q, Tong P, et al.

作者單位：南昌大學(xué)

使用產(chǎn)品：Human IL-8 ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38268027/

?

39.?Palmitoleic acid protects microglia from palmitate-induced neurotoxicity in vitro?(Plos one, IF=3.7)

發(fā)表時(shí)間：19 January 2024

作 ???者：Yu Q, Yang Y, Xu T, et al.

作者單位：浙江海洋大學(xué)

使用產(chǎn)品：Mouse IL-1β ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38241239/

?

40.?The predictive value of serum IL-17A and IL-6 expression in postoperative recurrence in patients with intrauterine adhesion?(American Journal of Reproductive Immunology, IF=3.6)

發(fā)表時(shí)間：14 January 2024

作 ???者：Cui X, Xiao H C, Pan W.

作者單位：南京醫(yī)科大學(xué)附屬常州二院

使用產(chǎn)品：Human IL-17A and IL-6 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38282600/

?

41.?Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function?(Diabetic Medicine, IF=3.5)

發(fā)表時(shí)間：07 January 2024

作 ???者：Xu W, Zhou Y, Wang T, et al.

作者單位：徐州醫(yī)科大學(xué)

使用產(chǎn)品：Mouse TGF-β1 and VCAM-1 ELISA kits

https://pubmed.ncbi.nlm.nih.gov/38185936/

?

42.?Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis?(Renal Failure, IF=3)

發(fā)表時(shí)間：10 January 2024

作 ???者：Hu X, Ding H, Wei Q, et al.

作者單位：東南大學(xué)

使用產(chǎn)品：Human FGF-21 ELISA kit

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783836/

?

43.?Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis?(PeerJ, IF=2.7)

發(fā)表時(shí)間：15 January 2024

作 ???者：Zhang J, Shi L, Duan J, et al.

作者單位：鄭州大學(xué)第三附屬醫(yī)院

使用產(chǎn)品：IHC kit

https://pubmed.ncbi.nlm.nih.gov/38239300/

?

44.?Gene polymorphisms of an interleukin-23 receptor associated with susceptibility to rheumatoid arthritis in the Western Chinese Han population?(International Journal of Immunogenetics, IF=2.2)

發(fā)表時(shí)間：09 January 2024

作 ???者：Ren R, Tan H, Wang X, et al.

作者單位：四川大學(xué)

使用產(chǎn)品：Human IL-17A ELISA kit

https://pubmed.ncbi.nlm.nih.gov/38196067/

欣博盛生物科技有限公司?

全國服務(wù)熱線: 4006-800-892? ? ? ? ? ??郵箱: market@neobioscience.com?

深圳: 0755-26755892?????北京:?010-88594029? ? ? ?上海:?021-34613729? ? ??

廣州: 020-87615159? ? ? ?香港:?852-69410778?

代理品牌網(wǎng)站: www.yuebanme.com?
自主品牌網(wǎng)站: www.neobioscience.net?